The interaction of immunomodulator muramyl dipeptide with peripheral 5-HT receptors: Overview of the current state

International Journal of Immunopharmacology

Volumn 21, Issue 3, 1999, Pages 227-232

  Ševčík, Jan ^a   Mašek, Karel ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

5 HT receptors; Muramyl dipeptide; Serotonin

Indexed keywords

CYPROHEPTADINE; CYTOKINE; FENCLONINE; LISURIDE; METHYSERGIDE; METITEPINE; MURAMYL PEPTIDE; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN RECEPTOR; IMMUNOLOGICAL ADJUVANT; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE;

BINDING SITE; CATTLE; DRUG MECHANISM; FISH; GUINEA PIG; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MOUSE; MUSCLE CONTRACTION; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SEROTONINERGIC SYSTEM; ANIMAL; CLASSIFICATION; DRUG EFFECT; PHYSIOLOGY;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; HUMANS; RECEPTORS, SEROTONIN;

EID: 0032586965     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(98)00079-4     Document Type: Article

References (39)

1. Arzt, E., Costas, M., Finkielman, S., and Nahmod, V. E. (1991). Serotonin inhibition of tumor necrosis factor-alpha synthesis by human monocytes. Life Sci., 48, 2557-2562.
2. Bogers, J. J., Pelckmans, P. A., Boeckxstaens, G. E., de Man, J. G., Herman, A. G., and van Maerke, Y. M. (1991). The role of nitric oxide in serotonin-induced relaxations in the canine terminal ileum and ileocolonic junction. Naunyn-Schmiedebergs Arch. Pharmacol., 344, 716-719.
3. 2A receptor. J. Neurochem., 63, 465-469.
4. Costa, M., and Furness, J. B. (1979). The sites of action of 5-hydroxytryptamine in nerve-muscle preparations from the guinea-pig small intestine and colon. Br. J. Pharmacol., 65, 237-248.
5. Devoino, L., Idova, G., Alperina, E., and Cheido, M. (1994). Brain neuromediator systems in the immune response control: pharmacological analysis of pre- and postsynaptic mechanisms. Brain Res., 633, 267-274.
6. 1-like receptor agonists enhance wakefulness. Neuropharmacology, 31, 623-633.
7. 2-receptors on longitudinal muscle of the guinea-pig ileum. J. Receptor Res., 4, 113-126.
8. Elliott, J. M., Newberry, N. R., Cholewinski, A. J., Bartrup, J. T., Briddon, S. J., Carey, J. E., Flanigan, T. P., Newton, R. A., Phipps, S. L., and Reavley, A. C. (1995). Characterization of the 5-hydroxytryptamine2A receptor-activated cascade in rat C6 glioma cells. Neuroscience, 69, 1119-1131.
9. Fillion, M. P., Prudhomme, N., Haour, F., Fillion, G., Bonnet, M., Lespinats, G., Mašek, K., Flegel, M., Corvaia, N., and Launay, J. M. (1989). Hypothetical role of the serotonergic system in neuromodulation: preliminary molecular studies. In J. W. Hadden, K. Mašek, and G. Nistico (Eds.), Interactions among central nervous system, neuroendocrine and immune systems (pp. 235-250). Rome/Milan: Pythagora Press.
10. Hoyer, D., and Martin, G. R. (1996). Classification and nomenclature of 5-HT receptors: a comment on current issues. Behav. Brain Res., 73, 263-268.
11. Humphrey, P. P. (1984). Peripheral 5-hydroxytryptamine receptors and their classification. Neuropharmacology, 23, 1503-1510.
12. Kadlec, O., Mašek, K., Gulda, O., Růžička, V., Parant, M., and Chedid, L. (1984). Smooth muscle stimulation by an immunomodulatory compound muramyl dipeptide: does it involve serotonergic system? Pharmacology, 29, 31-39.
13. Karnovsky, M. L. (1986). Muramyl peptides in mammalian tissues and their effects at the cellular level. Fed. Proc., 45, 2556-2560.
14. Kilbinger, H., and Pfeuffer-Friederich, I. (1985). Two types of receptors for 5-hydroxytryptamine on the cholinergic nerves of the guinea-pig myenteric plexus. Br. J. Pharmac., 85, 529-539.
15. Kojima, S., and Shimo, Y. (1986). The sites of action of 5-hydroxytryptamine in the longitudinal muscle of the guinea pig proximal colon. Asia Pacific J. Pharmacol., 1, 111-116.
16. Krueger, J. M., Walter, J., Dinarello, C. A., Wolff, S. M., and Chedid, L. (1984a). Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am. J. Physiol., 246, R994-R999.
17. Krueger, J. M., Walter, J. W., Karnovsky, M. L., Chedid, L., Choay, J. P., Lefrancier, P., and Lederer, E. (1984b). Muramyl peptides. Variation of somnogenic activity with structure. J. Exp. Med., 159, 68-76.
18. Martin, G. R., and Humphrey, P. P. A. (1994). Classification review. Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology, 33, 261-273.
19. Mašek, K. (1986). Immunopharmacology of muramylpeptides. Fed. Proc., 45, 2549-2551.
20. Mašek, K., Kadlecová, O., and Petrovický, P. (1978). Pharmacological activity of bacterial peptidoglycan: the effect on temperature and sleep in the rat. In P. Rosenberg (Ed.), Toxins: animal, plant and microbial (pp. 991-1003). New York: Pergamon Press.
21. Mašek, K., Horák, P., Kadlec, O., and Flegel, M. (1989). The interactions between neuroendocrine and immune systems at the receptors level. The possible role of serotonergic system. In J. W. Hadden, K. Mašek, and G. Nistico (Eds.), Interactions among central nervous system, neuroendocrine and immune systems (pp. 225-234). Rome/Milan: Pythagora Press.
22. 4 receptors mediate inhibition and facilitation of fast synaptic transmission in enteric neurones. Am. J. Physiol., 266, G230-G238.
23. Polanski, M., and Karnovsky, M. L. (1992). Serotonergic aspects of the response of human platelets to immune-adjuvant muramyl dipeptide. J. Neuroimmun., 37, 149-160.
24. 3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat. Eur. J. Pharmacol., 249, 259-264.
25. Ponzoni, A., Monti, J. M., Jantos, H., Altier, H., and Monti, D. (1995). Increased waking after intra-accumbens injection of m-chlorophenylbiguanide: prevention with serotonin or dopamine receptor antagonists. Eur. J. Pharmacol., 278, 111-115.
26. 2 receptor desensitization. Eur. J. Pharmacol., 238, 173-180.
27. Root-Bernstein, R. S., and Westall, F. C. (1990). Serotonin binding sites II. Muramyl dipeptide binds on myelin basic protein, LHRH and MSH-ACTH 4-10. Brain Res. Bull., 25, 827-841.
28. 2C receptors. Neuropharmacology, 33, 467-471.
29. Silverman, D. H., Wu, H., and Karnovsky, M. L. (1985). Muramyl peptides and serotonin interact at specific binding sites on macrophages and enhance superoxide release. Biochem. Biophys. Res. Commun., 131, 1161-1167.
30. Silverman, D. H., Imam, K., and Karnovsky, M. L. (1989). Muramylpeptide/serotonin receptors in brain-derived preparations. Peptide Res., 2, 338-344.
31. Silverman, D. H., Sayegh, M. H., Alvarez, C. E., Johnson, T. S., Milford, E. L., and Karnovsky, M. L. (1990). HLA class II-restricted binding of muramyl peptides to B lymphocytes of normal and narcoleptic subjects. Hum. Immunol., 27, 145-154.
32. Simpson, C. W., Ruwe, W. D., and Myers, R. D. (1994). Prostaglandins and hypothalamic neurotransmitter receptors involved in hyperthermia: a critical evaluation. Neurosci. Biobehav. Rev., 18, 1-20.
33. Slánský, J., Kadlec, O., Mašek, K., and Gulda, O. (1994). The effect of immunomodulator muramyl dipeptide (MDP) on serotoninergic response of isolated neuro-muscular preparations. Pharmacology, 48, 11-20.
34. Slánský, J., Kadlec, O., Ševčík, J., and Mašek, K. (1996). Further evidence on the interaction of muramyl dipeptide with serotonergic system. Int. J. Immunopharmacol., 18, 23-29.
35. 2 serotonergic receptor antagonists. J. Immunol., 137, 276-282.
36. Ševčík, J., Růžička, V., Slánský, J., and Mašek, K. (1996). Which type of 5-hydroxytryptamine receptor mediates relaxation of the longitudinal muscle of guinea-pig proximal colon in vitro? Methods Find. Exp. Clin. Pharmacol., 18, 421-430.
37. 3 receptor-mediated neurogenic relaxation of guinea-pig proximal colon? Jpn. J. Pharmacol., 77, 265-270.
38. Takeuchi, Y., Root-Bernstein, R. S., and Shih, J. C. (1990). Peptide displacement of [3H]5-hydroxytryptamine binding to bovine cortical membranes. Brain Res. Bull., 25, 817-820.
39. Woollard, D. J., Bornstein, J. C., and Furness, J. B. (1994). Characterization of 5-HT receptors mediating contraction and relaxation of the longitudinal muscle of guinea-pig distal colon in vitro. Naunyn-Schmiedebergs Arch. Pharmacol., 349, 455-462.